Cardiologyacute coronary syndromecardiovascular events
JCAD Protein: A Novel Predictor and Therapeutic Target for Residual Cardiovascular Risk in Acute Coronary Syndrome
By MedXY|Jul 30, 2026
JCAD, a junctional protein, independently predicts major adverse cardiovascular events (MACE) in acute coronary syndrome (ACS) patients with residual lipid and inflammatory risks, suggesting a key role in coagulation and fibrinolysis and a
